Challenges With the Development of Biomaterials for Sustainable Tissue Engineering

The field of tissue engineering has tantalizingly offered the possibility of regenerating new tissue in order to treat a multitude of diseases and conditions within the human body. Nevertheless, in spite of significant progress with in vitro and small animal studies, progress toward realizing the cl...

Full description

Bibliographic Details
Main Author: David F. Williams
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fbioe.2019.00127/full
_version_ 1819140685837631488
author David F. Williams
David F. Williams
author_facet David F. Williams
David F. Williams
author_sort David F. Williams
collection DOAJ
description The field of tissue engineering has tantalizingly offered the possibility of regenerating new tissue in order to treat a multitude of diseases and conditions within the human body. Nevertheless, in spite of significant progress with in vitro and small animal studies, progress toward realizing the clinical and commercial endpoints has been slow and many would argue that ultimate goals, especially in treating those conditions which, as yet, do not have acceptable conventional therapies, may never be reached because of flawed scientific rationale. In other words, sustainable tissue engineering may not be achievable with current approaches. One of the major factors here is the choice of biomaterial that is intended, through its use as a “scaffold,” to guide the regeneration process. For many years, effective specifications for these biomaterials have not been well-articulated, and the requirements for biodegradability and prior FDA approval for use in medical devices, have dominated material selection processes. This essay argues that these considerations are not only wrong in principle but counter-productive in practice. Materials, such as many synthetic bioabsorbable polymers, which are designed to have no biological activity that could stimulate target cells to express new and appropriate tissue, will not be effective. It is argued here that a traditional ‘scaffold’ represents the wrong approach, and that tissue-engineering templates that are designed to replicate the niche, or microenvironment, of these target cells are much more likely to succeed.
first_indexed 2024-12-22T11:42:29Z
format Article
id doaj.art-e98a8b9589f548839b448126ad407a8a
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-12-22T11:42:29Z
publishDate 2019-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-e98a8b9589f548839b448126ad407a8a2022-12-21T18:27:15ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852019-05-01710.3389/fbioe.2019.00127456529Challenges With the Development of Biomaterials for Sustainable Tissue EngineeringDavid F. Williams0David F. Williams1Wake Forest Institute of Regenerative Medicine, Winston-Salem, NC, United StatesStrait Access Technologies, Cape Town, South AfricaThe field of tissue engineering has tantalizingly offered the possibility of regenerating new tissue in order to treat a multitude of diseases and conditions within the human body. Nevertheless, in spite of significant progress with in vitro and small animal studies, progress toward realizing the clinical and commercial endpoints has been slow and many would argue that ultimate goals, especially in treating those conditions which, as yet, do not have acceptable conventional therapies, may never be reached because of flawed scientific rationale. In other words, sustainable tissue engineering may not be achievable with current approaches. One of the major factors here is the choice of biomaterial that is intended, through its use as a “scaffold,” to guide the regeneration process. For many years, effective specifications for these biomaterials have not been well-articulated, and the requirements for biodegradability and prior FDA approval for use in medical devices, have dominated material selection processes. This essay argues that these considerations are not only wrong in principle but counter-productive in practice. Materials, such as many synthetic bioabsorbable polymers, which are designed to have no biological activity that could stimulate target cells to express new and appropriate tissue, will not be effective. It is argued here that a traditional ‘scaffold’ represents the wrong approach, and that tissue-engineering templates that are designed to replicate the niche, or microenvironment, of these target cells are much more likely to succeed.https://www.frontiersin.org/article/10.3389/fbioe.2019.00127/fulltemplatebiocompatibilityscaffoldbiomaterialbiodegradation
spellingShingle David F. Williams
David F. Williams
Challenges With the Development of Biomaterials for Sustainable Tissue Engineering
Frontiers in Bioengineering and Biotechnology
template
biocompatibility
scaffold
biomaterial
biodegradation
title Challenges With the Development of Biomaterials for Sustainable Tissue Engineering
title_full Challenges With the Development of Biomaterials for Sustainable Tissue Engineering
title_fullStr Challenges With the Development of Biomaterials for Sustainable Tissue Engineering
title_full_unstemmed Challenges With the Development of Biomaterials for Sustainable Tissue Engineering
title_short Challenges With the Development of Biomaterials for Sustainable Tissue Engineering
title_sort challenges with the development of biomaterials for sustainable tissue engineering
topic template
biocompatibility
scaffold
biomaterial
biodegradation
url https://www.frontiersin.org/article/10.3389/fbioe.2019.00127/full
work_keys_str_mv AT davidfwilliams challengeswiththedevelopmentofbiomaterialsforsustainabletissueengineering
AT davidfwilliams challengeswiththedevelopmentofbiomaterialsforsustainabletissueengineering